| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1262349ee21a1b98e42c45029e033866 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2200-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2200-0647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-0861 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M23-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M23-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-502761 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-32 |
| filingDate |
2018-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6541bcb749ced9defa9985e0b2470f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b69f15fd90271296ca58922c68867f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e1d33cd9df9e8165593fad9fd3362c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97d4e8a141e772da9717877c90c0c336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c27fca4d56b5e2fc71554da33edf47cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72c4fb9003ec9260dc1263bcc3e15f13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76f300856e554b92a217f914dafe1306 |
| publicationDate |
2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200079029-A |
| titleOfInvention |
System for screening optimum anticancer drug using self-tumor and method thereof |
| abstract |
An optimal anticancer drug selection system using autologous tumors is provided. The optimal anticancer drug selection system using autologous tumors according to an embodiment of the present invention is a tumor/tissue production device that produces a large amount of three-dimensional tumors or three-dimensional normal tissues from cancer cells in a patient's tumor or target cells of a patient's tumor, and the produced 3 A tissue culture device for removing an anti-cancer drug after injecting and incubating different anti-cancer drugs for each pair of 3D tumors and 3D normal tissues, and a survival rate for detecting the survival rate of cells in 3D tumors and 3D normal tissues with anticancer drugs removed Includes a detection device and a screening device for screening an anticancer drug administered to a three-dimensional normal tissue having a cell viability of at least a second threshold or more as an optimal anticancer drug among anticancer drugs administered to a three-dimensional tumor having a cell viability of less than or equal to a first threshold do. |
| priorityDate |
2018-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |